C - Chemistry – Metallurgy – 12 – N
Patent
C - Chemistry, Metallurgy
12
N
C12N 5/071 (2010.01) A61K 31/727 (2006.01) A61K 38/00 (2006.01) A61K 38/36 (2006.01) A61K 38/55 (2006.01) A61K 39/395 (2006.01) A61K 35/39 (2006.01) C12N 11/10 (2006.01)
Patent
CA 2361949
The present invention is within the field of transplantation surgery. More closely, the present invention relates to use of a clotting preventing agent in the production of a drug for administration in association with transplantation of insulin producing cells in the form of isolated islets to patients with insulin dependent diabetes mellitus, IDDM. The invention is expected to significantly improve the clinical outcome of transplantation of islets of Langerhans.
La présente invention concerne le domaine des greffes, et plus particulièrement, l'utilisation d'un agent anti-coagulant dans la production d'un médicament à administrer en association avec la greffe de cellules productrices d'insuline, sous forme d'îlots isolés, à des patients présentant un diabète insulino-dépendant (DID). L'invention devrait améliorer de façon significative le résultat clinique des greffes d'îlots de Langerhans.
Bennet William
Korsgren Olle
Larsson Rolf
Nilsson Bo
Cassan Maclean
Corline Systems Ab
LandOfFree
Heparin, or heparin conjugate, islets of langerhans does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Heparin, or heparin conjugate, islets of langerhans, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Heparin, or heparin conjugate, islets of langerhans will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1625655